VERICEL CORPORATION Operating Lease Right-of-Use Assets
VERICEL CORPORATION (VCEL) had Operating Lease Right-of-Use Assets of $62.01 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-30
- 2026-06-30: Operating Lease, Right-of-Use Asset $62.01M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $63.41M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $64.77M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $66.09M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $62.01M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $63.41M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $64.77M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $66.09M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $67.40M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $68.72M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $70.10M 10-K · filed 2026-02-26 |
| 2024-09-30 | $71.56M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $73.02M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $73.68M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $73.46M 10-K · filed 2025-02-27 |
| 2023-09-30 | $73.29M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $75.06M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $40.85M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $41.53M 10-K · filed 2024-02-29 |
| 2022-09-30 | $42.63M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $43.58M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $44.65M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $45.72M 10-K · filed 2023-02-23 |
| 2021-09-30 | $46.71M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $47.80M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $48.94M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $50.10M 10-K · filed 2022-02-24 |
| 2020-09-30 | $24.80M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $23.80M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $24.50M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $25.10M 10-K · filed 2021-02-24 |
| 2019-09-30 | $25.62M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $24.82M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $25.18M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |